285
Views
27
CrossRef citations to date
0
Altmetric
Research Article

Preparation and in vivo evaluation of anti-plasmodial properties of artemisinin-loaded PCL–PEG–PCL nanoparticles

, , , &
Pages 911-920 | Received 24 May 2017, Accepted 23 Aug 2017, Published online: 11 Sep 2017

References

  • Anitha A, Maya S, Deepa N, Chennazhi KP, Nair SV, Tamura H, Jayakumar R. 2011. Efficient water soluble O-carboxymethyl chitosan nanocarrier for the delivery of curcumin to cancer cells. Carbohydr Polym. 83:452–461.
  • Bloland P, Ettling M. 1999. Making malaria-treatment policy in the face of drug resistance. Ann Trop Med Parasitol. 93:5–23.
  • Bloland PB, Williams HA. 2002. Malaria control during mass population movements and natural disasters. Washington DC: National Academies Press.
  • Borstnik K, Paik I-h, Shapiro TA, Posner GH. 2002. Antimalarial chemotherapeutic peroxides: artemisinin, yingzhaosu A and related compounds. Int J Parasitol. 32:1661–1667.
  • Bruce-Chwatt LJ. 1959. Malaria research and eradication in the USSR: a review of Soviet achievements in the field of malariology. Bull World Health Org. 21:737.
  • Danafar H, Hamidi M. 2013. A rapid and sensitive LC–MS method for determination of ezetimibe concentration in human plasma: application to a bioequivalence study. Chromatographia. 76:1667–1675.
  • Danafar H, Hamidi M. 2016. LC-MS method for studying the pharmacokinetics and bioequivalence of clonidine hydrochloride in healthy male volunteers. Avicenna J Med Biotechnol. 8:91–98.
  • Danafar H, Manjili H, Najafi M. 2016. Study of copolymer composition on drug loading efficiency of enalapril in polymersomes and cytotoxicity of drug loaded nanoparticles. Drug Res (Stuttg). 66:495–504.
  • Danafar H, Rostamizadeh K, Davaran S, Hamidi M. 2015. Drug-conjugated PLA–PEG–PLA copolymers: a novel approach for controlled delivery of hydrophilic drugs by micelle formation. Pharm Develop Technol. [1?11]. doi: 10.3109/10837450.2015.1125920
  • Danafar H, Rostamizadeh K, Hamidi M. 2017. Polylactide/poly (ethylene glycol)/polylactide triblock copolymer micelles as carrier for delivery of hydrophilic and hydrophobic drugs: a comparison study. J Pharm Investig. [1–11]. doi: 10.1007/s40005-017-0334-8
  • Danafar H, Sharafi A, Kheiri Manjili H, Andalib S. 2017. Sulforaphane delivery using mPEG–PCL co-polymer nanoparticles to breast cancer cells. Pharm Dev Technol. 22:642–651.
  • Danafar H. 2016. Applications of copolymeric nanoparticles in drug delivery systems. Drug Res (Stuttg). 66:506–519.
  • Danafar H. 2017. Study of the composition of polycaprolactone/poly (ethylene glycol)/polycaprolactone copolymer and drug-to-polymer ratio on drug loading efficiency of curcumin to nanoparticles. Jundishapur J Nat Pharm Prod. 12:e34179.
  • Danafar H, Hamidi M. 2015. Pharmacokinetics and bioequivalence study of amlodipine and atorvastatin in healthy male volunteers by LC-MS. Pharm Sci. 21:167–174.
  • Das A. 2015. Anticancer effect of antimalarial artemisinin compounds. Ann Med Health Sci Res. 5:93–102.
  • Diawara HZ, Gbaguidi F, Evrard B, Leclercq JQ, Moudachirou M, Debrus B, Hubert P, Rozet E. 2011. Validation, transfer and measurement uncertainty estimation of an HPLC–UV method for the quantification of artemisinin in hydro alcoholic extracts of Artemisia annua L. J Pharm Biomed Analy. 56:7–15.
  • Eckstein-Ludwig U, Webb RJ, Van Goethem IDA, East JM, Lee AG, Kimura M, O'Neill PM, Bray PG, Ward SA, Krishna S. 2003. Artemisinins target the SERCA of Plasmodium falciparum. Nature. 424:957–961.
  • Gharebaghi F, Dalali N, Ahmadi E, Danafar H. 2017. Preparation of wormlike polymeric nanoparticles coated with silica for delivery of methotrexate and evaluation of anticancer activity against MCF7 cells. J Biomater Appl. 31:1305–1316.
  • Goldberg M, Langer R, Jia X. 2007. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed. 18:241–268.
  • Hao J-y, Han W, Huang S-d, Xue B-y, Deng X. 2002. Microwave-assisted extraction of artemisinin from Artemisia annua L. Sep Purif Technol. 28:191–196.
  • Izadi A, Manjili HK, Ma’mani L, Moslemi E, Mashhadikhan M. 2015. Sulforaphane loaded PEGylated iron oxide-gold core shell nanoparticles: a promising delivery system for cancer therapy. Am Int J Contemp Sci Res. 2:84–94.
  • Kheiri Manjili HR, Malvandi H, Mosavi M-S, Danafar H. 2016. Preparation and physicochemical characterization of biodegradable mPEG-PCL coreshell micelles for delivery of artemisinin. Pharm Sci. 22:234–243.
  • Kheiri Manjili H, Sharafi A, Attari E, Danafar H. 2017. Pharmacokinetics and in vitro and in vivo delivery of sulforaphane by PCL–PEG–PCL copolymeric-based micelles. Artif Cells Nanomed Biotechnol. [1–12]. doi: 10.1080/21691401.2017.1282501
  • Lengeler C, Cattani J,D, Savigny D. 1996. Net Gain: a new method for preventing malaria deaths. Ottawa: IDRC.
  • Mahapatra RK, Behera N, Naik PK. 2012. Molecular modeling and evaluation of binding mode and affinity of artemisinin-quinine hybrid and its congeners with Fe-protoporphyrin-IX as a putative receptor. Bioinformation. 8:369.
  • Manjili HK, Jafari H, Ramazani A, Davoudi N. 2012. Anti-leishmanial and toxicity activities of some selected Iranian medicinal plants. Parasitol Res. 111:2115–2121.
  • Manjili HK, Ma’mani L, Tavaddod S, Mashhadikhan M, Shafiee A, Naderi-Manesh H. 2016. D, L-sulforaphane loaded Fe3O4@ gold core shell nanoparticles: a potential sulforaphane delivery system. PloS One. 11:e0151344.
  • Manjili HK, Malvandi H, Mousavi MS, Attari E, Danafar H. 2017. In vitro and in vivo delivery of artemisinin loaded PCL–PEG–PCL micelles and its pharmacokinetic study. Artif Cells Nanomed Biotechnol. [1–11]. doi: 10.1080/21691401.2017.1347880
  • Nomani A, Nosrati H, Manjili HK, Khesalpour L, Danafar H, Sinha V. 2017. Preparation and characterization of copolymeric polymersomes for protein delivery. Drug Res (Stuttg). 67:458–465.
  • Nosrati H, Salehiabar M, Davaran S, Ramzani A, Manjili HK, Danafar H. 2017. New advances strategies for surface functionalization of iron oxide magnetic nano particles (IONPs). Res Chem Intermed. doi: 10.1007/s11164-017-3084-3
  • Pan D, Fu Q, Lu J. 2012. Nanolithography through mixture of block copolymer micelles. Nanotechnology. 23:305302.
  • Ploypradith P. 2004. Development of artemisinin and its structurally simplified trioxane derivatives as antimalarial drugs. Acta Trop. 89:329–342.
  • Porbarkhordari E, Foladsaz K, Hoseini SH, Danafar H, Kheiri Manjili HR, Ramazani A. 2014. The hypoglycemic effects of an ethanol extract of peganum harmala in streptozotocin-induced diabetic rats. Iran J Pharm Sci. 10:47–54.
  • Ramazani A, Borna H. 2011. In silico analysis and develipment of anti- malarial compounds against dihydroorotate dehydrogenase using chembioinformatic tools. Int J Pharm Bio Sci. 2:122–131.
  • Ramazani A, Hamidnezhad R, Foroumadi A, Mirzaei SA, Maddahi S, Hassanzadeh SM. 2016. In vitro antiplasmodial activity and cytotoxic effect of (Z)-2-benzylidene-4, 6-dimethoxybenzofuran-3(2H)-one derivatives. Iran J Parasitol. 11:371–376.
  • Ramazani A, Sardari S, Zakeri S, Vaziri B. 2010a. In vitro antiplasmodial and phytochemical study of five Artemisia species from Iran and in vivo activity of two species. Parasitol Res. 107:593–599.
  • Ramazani A, Zakeri S, Sardari S, Khodakarim N, Djadidt ND. 2010b. In vitro and in vivo anti-malarial activity of Boerhavia elegans and Solanum surattense. Malar J. 9:124.
  • Rasoanaivo P, Wright CW, Willcox ML, Gilbert B. 2011. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malar J. 10:1.
  • Reisner DE. 2011. Bionanotechnology II: global prospects. vol. 2. Boca Raton (FL): CRC Press.
  • Sangian H, Faramarzi H, Yazdinezhad A, Mousavi SJ, Zamani Z, Noubarani M, Ramazani A. 2013. Antiplasmodial activity of ethanolic extracts of some selected medicinal plants from the northwest of Iran. Parasitol Res. 112:3697–3701.
  • Tilley L, Davis TM, Bray PG. 2006. Prospects for the treatment of drug-resistant malaria parasites. Future Microbiol. 1:127–141.
  • Uskoković V, Uskoković DP. 2011. Nanosized hydroxyapatite and other calcium phosphates: chemistry of formation and application as drug and gene delivery agents. J Biomed Mater Res. 96B:152–191.
  • Van Agtmael MA, Eggelte TA, van Boxtel CJ. 1999. Artemisinin drugs in the treatment of malaria: from medicinal herb to registered medication. Trends Pharmacol Sci. 20:199–205.
  • Vink H, Duling BR. 1996. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res. 79:581–589.
  • Woodrow C, Haynes R, Krishna S. 2005. Artemisinins. Postgrad Med J. 81:71–78.
  • World Health Organization 2008. World malaria report 2008. Geneva: World Health Organization.
  • Yeung S, Pongtavornpinyo W, Hastings IM, Mills AJ, White NJ. 2004. Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices. Am J Tropic Med Hygiene. 71(2 suppl):179–186.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.